2023 CBIIC in Suzhou Industrial Park on September 25-27, 2023.

LI Wenbin

Wenbin Li, Chief physician, Professor, Doctoral supervisor, Director of Cancer Center, Beijing Tiantan Hospital Affiliated to Capital Medical University,  Vice President of National Institute of Health Data Science at Capital Medical University, Director of Department of Clinical Oncology at Capital Medical University, Vice-Chairman & Secretary-General of PhIRDA Clinical Research on Cranial Nerve Drugs Specialty Committee, Minister of Department of Journal and Publishing of China Anti-Cancer Association, Vice chairman of Glioma Professional Committee,Editorial board member of《Signal Transduction and Targeted Therapy》and《Cancer  Biology  & Medical》, Editor-in-chief of 《China Health Standard Management 》, Editor-in-chief of Neuro-Oncology special issue of Medical Reference, Leading Talent of Beijing Traditional Chinese and Western Medicine, The famous doctor of China--Excellent demeanor in 2020, Honorary Research Fellow of University of South Florida of America. He is good at the comprehensive treatment of intracranial malignant tumors, and has presided over more than 20 domestic and international multi-center drug clinical trials, including two phase I clinical trials of national key innovative drugs in the 13th Five-Year Plan. China General coordinator for international multicenter clinical trial-GBM AGILE, and has published more than 100 academic papers.